Published in Materials (Basel) on March 26, 2013
Knitting for heart valve tissue engineering. Glob Cardiol Sci Pract (2016) 0.75
In Vitro Growth of Human Keratinocytes and Oral Cancer Cells into Microtissues: An Aerosol-Based Microencapsulation Technique. Bioengineering (Basel) (2017) 0.75
A new holistic 3D non-invasive analysis of cellular distribution and motility on fibroin-alginate microcarriers using light sheet fluorescent microscopy. PLoS One (2017) 0.75
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med (2017) 0.75
Bacterial alginate production: an overview of its biosynthesis and potential industrial production. World J Microbiol Biotechnol (2017) 0.75
Hydrogels for tissue engineering. Chem Rev (2001) 7.25
Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials (2003) 7.15
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum (2000) 4.52
The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng (2001) 3.91
Tissue-engineered bone regeneration. Nat Biotechnol (2000) 3.84
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv (2010) 2.65
Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.63
Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials (2004) 2.46
Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng (2007) 2.46
Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci (2002) 2.42
Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials (2001) 2.40
Polymer microspheres for controlled drug release. Int J Pharm (2004) 2.34
Encapsulating chondrocytes in degrading PEG hydrogels with high modulus: engineering gel structural changes to facilitate cartilaginous tissue production. Biotechnol Bioeng (2004) 1.97
Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res (2001) 1.95
Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev (2007) 1.94
Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog (2001) 1.91
Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials (2003) 1.77
Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74
Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials (2005) 1.74
Rational design of hydrogels for tissue engineering: impact of physical factors on cell behavior. Biomaterials (2006) 1.74
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol (2007) 1.58
Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials (2009) 1.54
Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. Biomaterials (2002) 1.50
Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials (2011) 1.43
An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials (2010) 1.42
Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials (2003) 1.39
Encapsulating chondrocytes in copolymer gels: bimodal degradation kinetics influence cell phenotype and extracellular matrix development. J Biomed Mater Res A (2004) 1.37
Macromolecular Monomers for the Synthesis of Hydrogel Niches and Their Application in Cell Encapsulation and Tissue Engineering. Prog Polym Sci (2008) 1.36
In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A (2004) 1.32
A rapid-curing alginate gel system: utility in periosteum-derived cartilage tissue engineering. Biomaterials (2004) 1.32
Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials (2005) 1.30
Crosslinking density influences the morphology of chondrocytes photoencapsulated in PEG hydrogels during the application of compressive strain. J Orthop Res (2004) 1.29
Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration. J Control Release (2005) 1.26
Alginate derivatization: a review of chemistry, properties and applications. Biomaterials (2012) 1.24
The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials (2010) 1.20
The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials (2009) 1.18
Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials (2005) 1.17
Calcium alginate gel: a biocompatible and mechanically stable polymer for endovascular embolization. J Biomed Mater Res (2001) 1.16
Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials (2009) 1.15
Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One (2011) 1.13
Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials (2010) 1.12
Preparation of aligned porous gelatin scaffolds by unidirectional freeze-drying method. Acta Biomater (2009) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs (2011) 1.09
Chondrogenic differentiation of human mesenchymal stem cells using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan copolymer. Biomaterials (2004) 1.08
Automated quantitative characterization of alginate/hydroxyapatite bone tissue engineering scaffolds by means of micro-CT image analysis. J Mater Sci Mater Med (2011) 1.07
Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. Macromol Biosci (2006) 1.06
Microcapsules of alginate-chitosan--I. A quantitative study of the interaction between alginate and chitosan. Biomaterials (1998) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials (2008) 1.04
Controlled in vivo degradation of genipin crosslinked polyethylene glycol hydrogels within osteochondral defects. Tissue Eng (2006) 1.04
Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci Mater Med (2004) 1.03
De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg (1996) 1.01
The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials (2010) 0.99
A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology. Biomaterials (2011) 0.98
The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater (2010) 0.98
New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules (2005) 0.98
Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering. Acta Biomater (2012) 0.98
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials (2010) 0.97
Microfluidic spinning of flat alginate fibers with grooves for cell-aligning scaffolds. Adv Mater (2012) 0.96
Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems. Biomaterials (2012) 0.95
In situ gelation of P(NIPAM-HEMA) microgel dispersion and its applications as injectable 3D cell scaffold. Biomacromolecules (2009) 0.95
Controlling Degradation of Hydrogels via the Size of Cross-Linked Junctions. Adv Mater (2004) 0.94
Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials (2003) 0.93
Controlled gelation and degradation rates of injectable hyaluronic acid-based hydrogels through a double crosslinking strategy. J Tissue Eng Regen Med (2011) 0.93
Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomater (2008) 0.92
Hydrogel droplet microarrays with trapped antibody-functionalized beads for multiplexed protein analysis. Lab Chip (2010) 0.92
Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration. Acta Biomater (2012) 0.91
Alginate and alginate/gelatin microspheres for human adipose-derived stem cell encapsulation and differentiation. Biofabrication (2012) 0.91
Influence of processing parameters on pore structure of 3D porous chitosan-alginate polyelectrolyte complex scaffolds. J Biomed Mater Res A (2011) 0.91
Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels. Acta Biomater (2008) 0.91
In vivo evaluation of porous hydroxyapatite/chitosan-alginate composite scaffolds for bone tissue engineering. Int J Biol Macromol (2012) 0.90
Design of porous polymeric scaffolds by gas foaming of heterogeneous blends. J Mater Sci Mater Med (2009) 0.90
Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J Gene Med (2000) 0.90
Novel multiarm PEG-based hydrogels for tissue engineering. J Biomed Mater Res A (2010) 0.89
Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials (2012) 0.89
Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng (2003) 0.89
Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials (2012) 0.87
Integrative design of a poly(ethylene glycol)-poly(propylene glycol)-alginate hydrogel to control three dimensional biomineralization. Biomaterials (2011) 0.87
Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for adipose tissue regeneration. Organogenesis (2011) 0.86
In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem Biophys Res Commun (2006) 0.85
Microenvironment of alginate-based microcapsules for cell culture and tissue engineering. J Biosci Bioeng (2012) 0.85
The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules. Biomaterials (2012) 0.85
Gelatin/chitosan/hyaluronan ternary complex scaffold containing basic fibroblast growth factor for cartilage tissue engineering. J Mater Sci Mater Med (2007) 0.85
Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering. Tissue Eng Part A (2012) 0.85
Alginate-whey protein granular microspheres as oral delivery vehicles for bioactive compounds. Biomaterials (2006) 0.84
In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharm (2012) 0.84
Light-addressable electrodeposition of cell-encapsulated alginate hydrogels for a cellular microarray using a digital micromirror device. Biomicrofluidics (2011) 0.83
A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects. J Mater Sci Mater Med (2011) 0.82
The design of biodegradable microcarriers for induced cell aggregation. Macromol Biosci (2010) 0.82
Fully defined in situ cross-linkable alginate and hyaluronic acid hydrogels for myocardial tissue engineering. Biomaterials (2012) 0.82
Chitosan scaffolds with BMP-6 loaded alginate microspheres for periodontal tissue engineering. J Microencapsul (2012) 0.82
The visualisation and speed of kill of wound isolates on a silver alginate dressing. Int Wound J (2012) 0.81
Synthesis and characterization of thermosensitive chitosan copolymer as a novel biomaterial. J Biomater Sci Polym Ed (2004) 0.81
Micropatterning of hydrogels on locally hydrophilized regions on PDMS by stepwise solution dipping and in situ gelation. Langmuir (2012) 0.81
Pharmaceutical and therapeutic applications of artificial cells including microencapsulation. Eur J Pharm Biopharm (1998) 0.81
Matrix molecule influence on chondrocyte phenotype and proteoglycan 4 expression by alginate-embedded zonal chondrocytes and mesenchymal stem cells. J Orthop Res (2012) 0.81
Double stimulus-induced stem cell aggregation during differentiation on a biopolymer hydrogel substrate. Chem Commun (Camb) (2013) 0.75